Company Overview and News

 
88 Energy: Plenty of reasons to be positive as conventional potential comes to fore

2018-09-05 proactiveinvestors.com.au
With cash in the bank and plans for new operations waiting in the wings, there are reasons for 88 Energy Ltd (LON:88E) to remain positive.
REMPF OEL RMP OTTEF RMP

 
[Press] 88E: RMP: Alaska Update - Rig Contract Executed

2018-08-30 oilvoice
The Board of Red Emperor Resources NL (ASX/AIM: RMP) (“Red Emperor” or the “Company”) is pleased to advise that consortium operator, 88 Energy Limited (ASX/AIM: 88E) via its wholly owned subsidiary, Captivate Energy Alaska, Inc, has executed a rigcontract for the drilling of the “Winx” Prospect, located on the Western Blocks, NorthSlope of Alaska.
REMPF RMP RMP

 
88 Energy signs rig contract ahead of start of Alaska drilling in Q1 2019

2018-08-29 proactiveinvestors.com.au
88 Energy Ltd (LON:88E) has signed a rig contract for the drilling of the Winx Prospect, located on the Western Blocks, North Slope of Alaska.
REMPF OEL RMP OTTEF RMP

 
[Press] RMP Executes Definitive Agreement for Alaska Acquisition

2018-07-30 oilvoice
The Board of Red Emperor Resources NL (ASX/AIM: RMP) (“Red Emperor” or the “Company”) is pleased to advise that it has executed “Definitive Agreements” in relation to the recently announced farm-in acquisition of four (4) highly prospective leases containing a significantly large oil prospect on the Alaska North Slope.
REMPF OEL RMP OTTEF RMP 88E

 
[Press] 88 Energy Limited Operations Update

2018-07-30 oilvoice
88 Energy Limited (ASX: 88E) (“88 Energy” or the “Company”) provides the following update related to its operations, located on the North Slope of Alaska.
REMPF OEL RMP OTTEF RMP 88E

 
88 Energy and Red Emperor Resources pull trigger on Alaska farm-in

2018-07-30 proactiveinvestors.com.au
88 Energy Limited (LON:88E, ASX:88E) and Red Emperor Resources NL (LON:RMP) are to acquire working interests in an oil prospect on the prolific Alaska North Slope.
REMPF OEL RMP OTTEF RMP 88E

2
[Press] 88 Energy: RMP to Acquire Interest in Large Alaskan Oil Prospect

2018-06-26 oilvoice
The Board of Red Emperor Resources NL (“Red Emperor” or the “Company”) is pleased to provide the following announcement with respect to an exciting new farm-in acquisition and upcoming drill program.
OISHF REMPF OEL RMP OTTEF OISHY RMP 88E OSH

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ASX:RMP / RED EMPEROR RESOURCES NL on message board site Silicon Investor.

URMP BLACK GOLD URMP BLACK GOLD URMP BLACK GOLD X_RAMP.COM, INC. (OTCBB : XRMP) X_RAMP.COM, INC. (OTCBB : XRMP) X_RAMP.COM, INC. (OTCBB : XRMP)